Pharmaceutical Raw Materials Rifampicin Bright red powder 13292-46-1 CAS NO.13292-46-1

Pharmaceutical Raw Materials Rifampicin Bright red powder 13292-46-1

Name: rifampicin
CAS Number: 13292-46-1
Molecular formula: C43H58N4O12
Molecular weight: 822.94
EINECS number: 236-312-0

How to know Rifampicin

Rifampicin (also known as Rifampin, naproxamycin, naproxenomycin, Weifu Xian, Xian Dao Lun, force complex or Liming Ding, INN: Rifampicin) is a benefit Fulfomycin family of a broad spectrum of antibiotics, Mycobacterium tuberculosis has a strong antibacterial effect on the Gram-positive or negative bacteria, viruses, etc. are also effective. A red or dark red crystalline powder that is insoluble in water. Usually capsules or tablets oral medication, and other anti-TB drugs synergistic effect, and delay the production of resistant strains. Mainly for the treatment of tuberculosis, meningitis and Staphylococcus aureus infection. Topical treatment of trachoma

Rifampicin Application

Use broad spectrum antibiotics. On Mycobacterium tuberculosis, Gram-positive bacteria and some Gram-negative bacteria have antibacterial or bactericidal effect. Mainly for drug-resistant tuberculosis and drug-resistant Staphylococcus aureus infection, leprosy also have a certain effect.
Use is a broad-spectrum antibiotics, and can enter the cell, is a full-effect fungicide, bactericidal strong

Use is a broad-spectrum antibiotics, bifidobacteria and Gram-positive, negative bacteria have a strong bactericidal effect
Use for pharmaceutical intermediates

Use broad spectrum antibiotics. On Mycobacterium tuberculosis, Gram-positive bacteria and some Gram-negative bacteria have antibacterial or bactericidal effect. Mainly for drug-resistant tuberculosis and drug-resistant Staphylococcus aureus infection, leprosy also have a certain effect. Is a broad-spectrum antibiotics, and can enter the cell, is a full-effect fungicide, bactericidal strong broad-spectrum antibiotics, bifidobacteria and Gram-positive, negative bacteria have a strong bactericidal effect for pharmaceutical intermediates with broad-spectrum antibacterial Effect, the Gram-positive cocci, Mycobacterium tuberculosis has a good antibacterial activity, antibacterial spectrum and rifampicin the same

Uses use with broad-spectrum antibacterial effect, Gram-positive cocci, Mycobacterium tuberculosis has good antibacterial activity, antibacterial spectrum and rifampicin the same
Use of raw materials (anti-tuberculosis antibiotics)

Use inhibits DNA recombination and protein insertion into mature viral particles. The initiation of RNA synthesis is inhibited by the [beta] -subunit that binds RNA polymerase.